BeiGene (ONC) revenue breakdown

Healthcare · Biotechnology · Market cap $34.1B

By product, Product revenue, net is the largest at 99% of fiscal 2025 revenue, growing 116% a year over 7 years.

By region, United States is the largest at 54% of fiscal 2025 revenue; PRC grew fastest, 70% a year over 8 years.

Revenue by product

Fiscal years, as BeiGene reports them in its 10-K filings; fiscal 2025 total $5.3B.

Products20172018201920212022202320242025Share
Product revenue, net$24M$131M$223M$634M$1.3B$2.2B$3.8B$5.3B 99%
Other revenue$214M$67M$206M$542M$161M$269M$31M$61M 1%

Revenue by region

Fiscal years, as BeiGene reports them in its 10-K filings; fiscal 2025 total $5.3B.

Regions201720182019202020212022202320242025Share
United States$138M$43M$135M$18M$495M$503M$1.1B$2.0B$2.9B 54%
PRC$24M$132M$222M$291M$517M$840M$1.1B$1.4B$1.7B 31%
Europe- total revenue————$163M$63M$202M$363M$611M 11%
Other——$72M—$863,000$10M$27M$79M$172M 3%
Other$76M$23M——————— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ONC.
Open ONC in Investingly

Questions

Where does BeiGene make its money?

In fiscal 2025, by product: Product revenue, net $5.3B, Other revenue $61M.

From BeiGene's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.